Logo image of OSH

Oak Street Health Inc (OSH) Stock Fundamental Analysis

NYSE:OSH - New York Stock Exchange, Inc. - US67181A1079 - Common Stock - Currency: USD

39  +0.03 (+0.08%)

After market: 38.98 -0.02 (-0.05%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OSH. OSH was compared to 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of OSH have multiple concerns. OSH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year OSH has reported negative net income.
In the past year OSH has reported a negative cash flow from operations.
In the past 5 years OSH always reported negative net income.
OSH had a negative operating cash flow in each of the past 5 years.
OSH Yearly Net Income VS EBIT VS OCF VS FCFOSH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 -100M -200M -300M -400M -500M

1.2 Ratios

OSH has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OSH Yearly ROA, ROE, ROICOSH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 200 -200 400 -400 -600

1.3 Margins

OSH's Gross Margin of 3.61% is on the low side compared to the rest of the industry. OSH is outperformed by 80.00% of its industry peers.
OSH's Gross Margin has declined in the last couple of years.
OSH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.28%
GM growth 5Y-35.39%
OSH Yearly Profit, Operating, Gross MarginsOSH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 20 -20

More info and screens

3

2. Health

2.1 Basic Checks

OSH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OSH has been increased compared to 1 year ago.
The debt/assets ratio for OSH has been reduced compared to a year ago.
OSH Yearly Shares OutstandingOSH Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M
OSH Yearly Total Debt VS Total AssetsOSH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 1.98 indicates that OSH is not a great score, but indicates only limited risk for bankruptcy at the moment.
OSH has a Altman-Z score of 1.98. This is comparable to the rest of the industry: OSH outperforms 58.26% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.98
ROIC/WACCN/A
WACC7.66%
OSH Yearly LT Debt VS Equity VS FCFOSH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 200M -200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.41 indicates that OSH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.41, OSH is in line with its industry, outperforming 50.43% of the companies in the same industry.
OSH has a Quick Ratio of 1.41. This is a normal value and indicates that OSH is financially healthy and should not expect problems in meeting its short term obligations.
OSH has a Quick ratio of 1.41. This is comparable to the rest of the industry: OSH outperforms 58.26% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
OSH Yearly Current Assets VS Current LiabilitesOSH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

More info and screens

6

3. Growth

3.1 Past

The earnings per share for OSH have decreased strongly by -20.11% in the last year.
Looking at the last year, OSH shows a very strong growth in Revenue. The Revenue has grown by 50.84%.
Measured over the past years, OSH shows a very strong growth in Revenue. The Revenue has been growing by 63.49% on average per year.
EPS 1Y (TTM)-20.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.68%
Revenue 1Y (TTM)50.84%
Revenue growth 3Y57.17%
Revenue growth 5Y63.49%
Sales Q2Q%46.59%

3.2 Future

Based on estimates for the next years, OSH will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.84% on average per year.
The Revenue is expected to grow by 32.73% on average over the next years. This is a very strong growth
EPS Next Y27.65%
EPS Next 2Y22.71%
EPS Next 3Y20.89%
EPS Next 5Y18.84%
Revenue Next Year42.14%
Revenue Next 2Y39.41%
Revenue Next 3Y36.49%
Revenue Next 5Y32.73%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OSH Yearly Revenue VS EstimatesOSH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
OSH Yearly EPS VS EstimatesOSH Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OSH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OSH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSH Price Earnings VS Forward Price EarningsOSH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSH Per share dataOSH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as OSH's earnings are expected to grow with 20.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.71%
EPS Next 3Y20.89%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OSH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Oak Street Health Inc

NYSE:OSH (5/1/2023, 8:04:01 PM)

After market: 38.98 -0.02 (-0.05%)

39

+0.03 (+0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-08 2023-05-08/amc
Earnings (Next)07-31 2023-07-31/amc
Inst Owners0.66%
Inst Owner Change0%
Ins Owners0.88%
Ins Owner Change0%
Market Cap9.52B
Analysts64.76
Price Target38.29 (-1.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.48%
Min EPS beat(2)5.91%
Max EPS beat(2)9.05%
EPS beat(4)2
Avg EPS beat(4)-11.68%
Min EPS beat(4)-51.53%
Max EPS beat(4)9.05%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.12%
Min Revenue beat(2)0.11%
Max Revenue beat(2)0.12%
Revenue beat(4)3
Avg Revenue beat(4)0%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)0.42%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.64%
EPS NQ rev (1m)0.81%
EPS NQ rev (3m)0.97%
EPS NY rev (1m)-1.24%
EPS NY rev (3m)6.05%
Revenue NQ rev (1m)-0.57%
Revenue NQ rev (3m)0.08%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.4
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.21
EYN/A
EPS(NY)-1.6
Fwd EYN/A
FCF(TTM)-1.63
FCFYN/A
OCF(TTM)-1.27
OCFYN/A
SpS8.86
BVpS-1.11
TBVpS-1.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.61%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.28%
GM growth 5Y-35.39%
F-Score4
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 253.41%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z 1.98
F-Score4
WACC7.66%
ROIC/WACCN/A
Cap/Depr(3y)298.69%
Cap/Depr(5y)374.46%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.68%
EPS Next Y27.65%
EPS Next 2Y22.71%
EPS Next 3Y20.89%
EPS Next 5Y18.84%
Revenue 1Y (TTM)50.84%
Revenue growth 3Y57.17%
Revenue growth 5Y63.49%
Sales Q2Q%46.59%
Revenue Next Year42.14%
Revenue Next 2Y39.41%
Revenue Next 3Y36.49%
Revenue Next 5Y32.73%
EBIT growth 1Y-11.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year46.47%
EBIT Next 3Y26.13%
EBIT Next 5Y17.47%
FCF growth 1Y-43.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.9%
OCF growth 3YN/A
OCF growth 5YN/A